Integrative enrichment analysis: a new computational method to detect dysregulated pathways in heterogeneous samples

Abstract

BackgroundPathway enrichment analysis is a useful tool to study biology and biomedicine, due to its functional screening on well-defined biological procedures rather than separate molecules. The measurement of malfunctions of pathways with a phenotype change, e.g., from normal to diseased, is the key issue when applying enrichment analysis on a pathway. The differentially expressed genes (DEGs) are widely focused in conventional analysis, which is based on the great purity of samples. However, the disease samples are usually heterogeneous, so that, the genes with great differential expression variance (DEVGs) are becoming attractive and important to indicate the specific state of a biological system. In the context of differential expression variance, it is still a challenge to measure the enrichment or status of a pathway. To address this issue, we proposed Integrative Enrichment Analysis (IEA) based on a novel enrichment measurement.ResultsThe main competitive ability of IEA is to identify dysregulated pathways containing DEGs and DEVGs simultaneously, which are usually under-scored by other methods. Next, IEA provides two additional assistant approaches to investigate such dysregulated pathways. One is to infer the association among identified dysregulated pathways and expected target pathways by estimating pathway crosstalks. The other one is to recognize subtype-factors as dysregulated pathways associated to particular clinical indices according to the DEVGs’ relative expressions rather than conventional raw expressions. Based on a previously established evaluation scheme, we found that, in particular cohorts (i.e., a group of real gene expression datasets from human patients), a few target disease pathways can be significantly high-ranked by IEA, which is more effective than other state-of-the-art methods. Furthermore, we present a proof-of-concept study on Diabetes to indicate: IEA rather than conventional ORA or GSEA can capture the under-estimated dysregulated pathways full of DEVGs and DEGs; these newly identified pathways could be significantly linked to prior-known disease pathways by estimated crosstalks; and many candidate subtype-factors recognized by IEA also have significant relation with the risk of subtypes of genotype-phenotype associations.ConclusionsTotally, IEA supplies a new tool to carry on enrichment analysis in the complicate context of clinical application (i.e., heterogeneity of disease), as a necessary complementary and cooperative approach to conventional ones.Electronic supplementary materialThe online version of this article (doi:10.1186/s12864-015-2188-7) contains supplementary material, which is available to authorized users.

Individual-specific edge-network analysis for disease prediction

“…Based on the differential expression mean, differential expression variance and differential expression co-variance ( 18 , 19 ), we extend the ENA framework to iENA, which has been implemented for the analysis on personalized disease prediction, e.g. influenza infection and cancer deteriorations.…”

Identification of COVID-19 Infection-Related Human Genes Based on a Random Walk Model in a Virus–Human Protein Interaction Network

“…The random walk with restart (RWR) algorithm, one of the typical network-based feature ranking algorithms [ 23 , 24 ], can simulate a random walker that starts from one or several seed nodes and walks on a network.…”

Identifying Essential Methylation Patterns and Genes Associated With Stroke

“…According to the probe annotation table of Illumina Human-Methylation450 BeadChip [18], [19], our selected methylation probes were mapped onto detailed genes, which were then enriched onto GO and KEGG through a hypergeometric test [35]. The GO and KEGG terms with false discovery rate smaller than 0.05 were considered as relevant biological functions with significant enrichment on our selected features.…”